203 Population pharmacokinetics of MEDI4736, a fully human antiprogrammed death ligand 1 (PD-L1) monoclonal antibody, in patients with advanced solid tumors. (September 2015) - Song, X.; Pak, M.; Chavez, C.; Liang, M.; Lu, H.; Blake-Haskins, A.J.; Robbins, P.B.; Jin, X.; Gupta, A.; Roskos, L.; Narwal, R.